Augtyro

BMS gets US approval for ROS1 lung cancer drug Augtyro
Pharmaphorum
Thu, 11/16/23 - 10:11 am
Bristol Myers Squibb
Augtyro
Turning Point Therapeutics
lung cancer
FDA